Skip To Main Content
Drs Lize Angelo on Muck Rack

Drs Lize Angelo

As seen in: New Zealand Optics
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Drs Lize

Contact Drs Lize, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Referral know how with Counties

|
By Drs Lize Angelo
| New Zealand Optics Verified
Seeking to improve engagement and co-management of patients, Counties Manukau SuperClinic hosted an inaugural optometry open evening. Inspired by private practices’ CPD evenings, Counties optometrists and organisers Deepa Kumar, Sandhya Mathew and Debra So said they hoped the event would clear up any questions referring optometrists may have and offer a better understanding of the patient journey at Counties.
Open in Who Shared Issue with article?

LETTER: Keratoconus management in NZ

|
By Drs Lize Angelo
| New Zealand Optics Verified
Kia ora Drs Lize Angelo and Akilesh Gokul and congratulations on your paper, ‘Current state of keratoconus management in New Zealand’ (published in NZ Optics’ April 2024 issue) and the important contribution you are making to the care of keratoconus patients in Aotearoa. You imply on several occasions that assessment of keratoconus assessment and corneal crosslinking (CXL) is a ‘tertiary centre’ procedure.
Open in Who Shared Issue with article?

Orally delivered drugs in clinical trials for DR: looking into the future

|
By Drs Lize Angelo
| New Zealand Optics Verified
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, laser panretinal photocoagulation and intravitreal corticosteroid implants are clinically used to resolve diabetic macular oedema (DMO), the most common cause of vision loss in diabetic retinopathy (DR) patients. However, these are only indicated for patients who have developed sight-threatening DR.
Open in Who Shared Issue with article?
See all 5 articles